AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
NCT ID: NCT04431544
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
513 participants
OBSERVATIONAL
2020-09-29
2023-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation
NCT04904354
A Fib Clinic of the Future Using KardiaPro Platform for Chronic Care of Patients With AF After Ablation Procedure
NCT03557034
Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF
NCT03064451
AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study)
NCT05181878
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
NCT05883631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AcQMap System
To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study.
Willing and able to give written informed consent.
Exclusion Criteria
Current enrollment in any study protocol sponsored by Acutus Medical. Any other condition that, in the judgment of the investigator, makes the participant a poor candidate for this procedure, the study, or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, extensive travel away from the research center, etc.).
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acutus Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grandview Medical Group Research
Birmingham, Alabama, United States
Banner University Medical Institute
Phoenix, Arizona, United States
St Jude Medical Center
Fullerton, California, United States
University California San Diego
La Jolla, California, United States
Keck School of Medicine of USC
Los Angeles, California, United States
Mission Heritage Mission Viejo - Cardiac Electrophysiology
Mission Viejo, California, United States
Eisenhower Medical Center
Rancho Mirage, California, United States
Dignity Health Research Institute
Sacramento, California, United States
Bethesda Hospital East
Boynton Beach, Florida, United States
Clearwater Cardiovascular Consultants
Clearwater, Florida, United States
Ascension St. Vincent's Medical Center Riverside
Jacksonville, Florida, United States
Celebration Hospital
Orlando, Florida, United States
Sarasota Memorial Research Institute
Sarasota, Florida, United States
Bayfront (Orlando Health)
St. Petersburg, Florida, United States
Saint Alphonsus Health System
Boise, Idaho, United States
Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States
Baptist Lexington Medical Center
Lexington, Kentucky, United States
Henry Ford Health Center
Detroit, Michigan, United States
Nevada Heart and Vascular
Las Vegas, Nevada, United States
Morristown Medical Center
Morristown, New Jersey, United States
Weill Cornell Medicine, New York Presbyterian Hospital
New York, New York, United States
ProMedica Physician Cardiology
Toledo, Ohio, United States
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
Methodist Healthcare
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLP-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.